Table 2. Clinical characteristics of patients admitted with RSV infection or influenza, Washington, USA, 2012–2017*.
| Characteristic | RSV, n = 158 | Influenza, n = 712 | Univariable p value |
|---|---|---|---|
| Mean length of hospital stay, d | 5.5 | 4.6 | 0.67 |
| ICU admission | 39 (25) | 123 (17) | 0.041 |
| Mean length of ICU stay, d | 3.5 | 3.6 | 0.86 |
| Readmission within 30 d | 40 (25) | 79 (11) | <0.001 |
| Patients fitting SIRS criteria at admission | 78 (49) | 309 (43) | 0.18 |
| Antimicrobial drugs used† | 84 (53) | 224 (31) | <0.001 |
| Steroids used | 22 (14) | 61 (9) | 0.05 |
| Deaths | 7 (4) | 21 (3) | 0.61 |
*Values are no. (%) unless otherwise noted. Four patients were admitted twice with influenza, and 1 patient was admitted twice with RSV infection. ICU, intensive care unit; RSV, respiratory syncytial virus; SIRS, systemic inflammatory response syndrome. †Included vancomycin, ceftriaxone, meropenem, azithromycin, levofloxacin, ciprofloxacin, amoxicillin, piperacillin/tazobactam, or ampicillin.